American Pharmacists Association (APhA)
FDANonrulemakingFDA-2026-N-0826

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – United States (U.S.) 2026-2027 Influenza Vaccine Strain Composition

RIN
Last modified
Feb 12, 2026
Comment window
closed 139d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Mar 4, 2026 and Mar 4, 2026. 4 other organizations filed here. The comment window closed 139d ago.

What American Pharmacists Association (APhA) filed (1)

Mar 4, 2026· Comment from American Pharmacists Association· FDA-2026-N-0826-0009

Dear Vaccines and Related Biological Products Advisory Committee: The American Pharmacists Association (APhA) appreciates the opportunity to provide comments to the Vaccines and Related Biological Products Advisory Committee on the role of pharmacists in administering vaccines, the importance of maintaining a consistent meeting cadence, and the ways mRNA technologies promote vaccine research and advance public health. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.

Abstract

No abstract recorded.

View on regulations.gov →
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – United States (U.S.) 2026-2027 Influenza Vaccine Strain Composition (FDA) — American Pharmacists Association (APhA) | OpenPolis